# Second Clinical Evaluation of THERANOVA-500 Dialyzer in Chronic Hemodialysis (HD)

> **NCT03618368** · NA · UNKNOWN · sponsor: **Réseau de Santé Vitalité Health Network** · enrollment: 70 (actual)

## Conditions studied

- End Stage Renal Disease on Dialysis

## Interventions

- **DEVICE:** THERANOVA-500 dialyzer
- **DEVICE:** REVACLEAR-400 dialyzer

## Key facts

- **NCT ID:** NCT03618368
- **Lead sponsor:** Réseau de Santé Vitalité Health Network
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-25
- **Primary completion:** 2018-10-23
- **Final completion:** 2021-06-04
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2020-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03618368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03618368, "Second Clinical Evaluation of THERANOVA-500 Dialyzer in Chronic Hemodialysis (HD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03618368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*